The projections I give in the OP are 78, 81 and 81 wins in 2017-19. I'm curious. What are your expectations.
My expectations are around .500 in 2017, a good team in 2018, and beginning to shape into a contender by 2019.
The projections I give in the OP are 78, 81 and 81 wins in 2017-19. I'm curious. What are your expectations.
My expectations are around .500 in 2017, a good team in 2018, and beginning to shape into a contender by 2019.
To me the word projection doesn't mean fact. I would use a stronger word than good to describe a team I exped to win 88-90 games.First, you said 'below-.500' initially for 2018, then changed it to 81 wins. Second, I think we'll be a good team in 2018, meaning somewhere around 88-90 wins. That's not similar to what you said.
And third, you essentially stated it as a fact. That was my primary issue with it. Again, if you want to say it's a possibility, or even make a prediction, that we'll be below-.500 in 2018, fine. To say that is where we'll be is ludicrous to me.
To me the word projection doesn't mean fact. I would use a stronger word than good to describe a team I exped to win 88-90 games.
Here’s my shot at compiling an 81 win scenario (33 WAR) for 2017 with what I feel are realistic assumptions. Overall payroll for this team is $120m, and only two of our current backend SP types are traded.
SP (12 WAR, $22m)
Teheran (3 WAR, $6.5m)
Newcomb / Blair / Wisler (3 WAR, $0.5m): Only one of these three emerges from the pack as a mid-rotation SP. The rest are hurt, or performing like backend SPs.
Brett Anderson (2 WAR, $13m): Doesn’t have to be Anderson specifically, but I think we’ll sign a mid-level vet.
Backend SPs (4 WAR, $2.0m): This accounts for the 4th and 5th rotation spots and spot-starts accumulated by our pre-arb SPs. Depth at the backend is a strength of our team.
RP (3 WAR, $15m)
Not going deep on this one, but plan would be to add 2-3 vets to what we already have. 3 WAR is just an average bullpen.
C (2 WAR, $6m)
We add Alex Avila to share time with Flowers. Neither hit well, and most of the value comes from Flowers’ defense.
1B (4 WAR, $21m)
Freeman
2B (1 WAR, $7m)
We sign a vet and he ruptures his achilles in ST. We try Jace, Castro, and Camargo here and none of them emerge. Albies not ready.
SS (3 WAR, $17m)
Aybar accepts the QO, and is just okay. Swanson is called up in the Summer after an Aybar injury and performs well.
3B (2 WAR, $13m)
Prado is signed for $10m AAV. KJ also sees time here due to injuries. Ruiz is a bust.
RF (3 WAR, $3m)
Inciarte takes over after Markakis is traded in 2016. He is a super two.
CF (2 WAR, $6m)
Mallex does not emerge as an everyday regular. Splits time with Rajai Davis.
LF (1 WAR, $10m)
Comedy of errors. Olivera performs poorly, then gets hurt. We trade a couple backend SP prospects for a backfill, and that player does not meet expectations.